Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges - review article. Youssry I, Ayad N. Ann Hematol 2024;103:2613-2619.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Youssry I, Ayad N. Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges - review article. Ann Hematol 2024;103:2613-2619.
PMID: 37867187